Original Article
Ability of Peripheral DXA Measurement to Diagnose Osteoporosis As Assessed By Central DXA Measurement

https://doi.org/10.1385/JCD:7:1:111Get rights and content

Abstract

In order to evaluate the utility of peripheral measurement of bone mineral density (BMD) in the diagnosis of osteoporosis, we measured BMD at the spine and femoral neck with central dual-energy X-ray absorptiometry (DXA), at phalanx with AccuDXA (Schick) as well as proximal and distal forearm with pDXA (Norland) in 835 women ranging in age from 20 to 85 yr. In receiver operating characteristic (ROC) curves, where a positive case was defined as a T-score ≤ –2.5 either on spine or femoral neck, the areas under the curve were not significantly different between sites. At a T-score of –2.5 as determined by each peripheral apparatus, sensitivity and specificity were, respectively, 0.39 and 0.95 for phalanx and 0.75 and 0.85 for proximal forearm whereas they were 0.42 and 0.96 for distal forearm. Using optimal absolute BMD cutoff values improved the results. Sensitivity and specificity were, respectively, 0.79 and 0.83 for phalanx at an absolute BMD value of 0.436 and 0.84 and 0.79 for proximal forearm at a value of 0.703, whereas they were 0.90 and 0.75 for distal forearm at a value of 0.208. Combining the two forearm measurements improves the results slightly. At cutoff values of 0.641 and 0.252, respectively for proximal and distal forearms, sensitivity was 0.83 and specificity was 0.84. Therefore, a peripheral measurement of BMD together with a good clinical evaluation of the osteoporosis risk profile of the patient, can be an interesting tool for the diagnosis of osteoporosis in areas where central DXA is not available.

References (25)

  • DA Micheali et al.

    A new x-ray based osteoporosis screening tool provides accurate and precise assessment of phalanx bone mineral content

    J Clin Densitom

    (1998)
  • SL Greenspan et al.

    Classification of osteoporosis in the elderly is dependent on site-specific analysis

    Calcif Tissue Int

    (1996)
  • Cited by (42)

    • Progestin-only contraception prevents bone loss in postpartum breastfeeding women

      2012, Contraception
      Citation Excerpt :

      We used forearm peripheral dual-energy X-ray absorptiometry, even knowing that, according to the current standards, axial skeletal sites are considered the gold standard approach for the diagnosis and monitoring of osteoporosis. However, studies have demonstrated that the forearm BMD correlates well with central BMD measurements (such as lumbar and total hip) [23–25], and this evaluation has been used in previous studies of BMD in DMPA users [25–27]. Our study has some limitations such as not taking into account dietary calcium intake, women's previous history of contraceptive use, history of family osteoporosis and other risk factors for bone loss.

    • A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate

      2011, Contraception
      Citation Excerpt :

      It should be noted that the USFDA's Black Box [8] and the WHO declaration [7] as well as the statement from the ACOG [12] and that produced during the Canadian consensus [13] make contrasting recommendations, as the latter two declarations did not advise any restriction regarding the length of DMPA use [14]. Despite the evidence that use of DMPA is associated with a reduction on BMD at different sites of the skeleton including measurement at forearm [15–21], there are scarce data regarding the skeletal health impact of this contraceptive method on long-term users and also the impact of DMPA use on fractures and fracture risk [22–27]. Consequently, the objective of this study was to assess forearm BMD of a cohort of women who have been using DMPA as a contraceptive method for as long as 15 years uninterruptedly and compared them with never users of the method.

    • Age-Related Trends in Phalangeal Bone Mineral Density in Sri Lankan Men and Women Aged 20 Years or More

      2009, Journal of Clinical Densitometry
      Citation Excerpt :

      However, the lack of reference data on local population and limited knowledge on clinical applications of these devices has created an uncertainty among clinicians. Although, PBMD is not used to diagnose osteoporosis (6) or to monitor the therapeutic efficacy of antiresorptive drugs (7), its ability to predict fractures has been proven in epidemiological studies (8). Despite limitations in clinical applications, these peripheral devices will remain available for clinicians, as central DXA facility is available only in few major cities in Sri Lanka.

    View all citing articles on Scopus
    View full text